Bank of America
DMRA

Bank of America’s Damora Therapeutics DMRA Stock Holding History

Bank of America’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56M Buy
98,284
+82,637
+528% +$2M ﹤0.01% 4039
2026
Q1 		$405K Buy
15,647
+14,419
+1,174% +$371K ﹤0.01% 5009
2025
Q4 		$28.3K Sell
1,228
-5,272
-81% -$91.6K ﹤0.01% 5978
2025
Q3 		$24.2K Buy
6,500
+5,272
+429% +$17.9K ﹤0.01% 7035
2025
Q2 		$4.19K Buy
1,228
+2
+0.2% +$6 ﹤0.01% 7325
2025
Q1 		$3.8K Hold
1,226
– – ﹤0.01% 7258
2024
Q4 		$5.7K Buy
1,226
+1
+0.1% +$7 ﹤0.01% 7081
2024
Q3 		$14.9K Buy
1,225
+2
+0.2% +$26 ﹤0.01% 6805
2024
Q2 		$14.5K Buy
1,223
+7
+0.6% +$111 ﹤0.01% 6813
2024
Q1 		$23.7K Hold
1,216
– – ﹤0.01% 6721
2023
Q4 		$21.9K Sell
1,216
-104
-8% -$1.6K ﹤0.01% 6771
2023
Q3 		$23.7K Sell
1,320
-605
-31% -$23.8K ﹤0.01% 6681
2023
Q2 		$121K Sell
1,925
-166
-8% -$9.04K ﹤0.01% 6122
2023
Q1 		$104K Buy
2,091
+95
+5% +$5.01K ﹤0.01% 6242
2022
Q4 		$57.4K Buy
1,996
+122
+7% +$5.06K ﹤0.01% 6430
2022
Q3 		$89K Buy
1,874
+394
+27% +$20K ﹤0.01% 6397
2022
Q2 		$64K Buy
1,480
+27
+2% +$1.24K ﹤0.01% 6714
2022
Q1 		$80K Sell
1,453
-66
-4% -$3.71K ﹤0.01% 6972
2021
Q4 		$115K Buy
1,519
+20
+1% +$1.57K ﹤0.01% 6818
2021
Q3 		$135K Buy
1,499
+79
+6% +$8.45K ﹤0.01% 6548
2021
Q2 		$180K Buy
1,420
+1,222
+617% +$166K ﹤0.01% 6161
2021
Q1 		$30K Buy
198
+18
+10% +$4.9K ﹤0.01% 6780
2020
Q4 		$56K Buy
+180
New +$67K ﹤0.01% 6278

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Bank of America's DMRA Position: Q2 2026 in Review

Bank of America increased its Damora Therapeutics (DMRA) stake by 528% in Q2 2026, buying an estimated $2M and bringing the position to 98,284 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #4039.

Bank of America first reported a position in DMRA in Q4 2020 and has held it in 23 quarters since. 104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

  • Bank of America held 98,284 shares of Damora Therapeutics worth $2.56M as of Q2 2026.
  • Bank of America bought 82,637 Damora Therapeutics shares in Q2 2026, an estimated $2M.
  • Damora Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4039 holding.
  • Bank of America first reported a position in Damora Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.